Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Cheung · SciRah

Researcher profile · Semantic Scholar

M. Cheung

Share profile

M. Cheung — researcher profile on SciRah

h-index: 31
Works: 284
Citations: 4,184

Most-cited papers

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
H. Tilly, F. Morschhauser, L. Sehn, J. Friedberg +28 more
2021New England Journal of Medicine735 citations Open access
Semantic Scholar
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.
J. Mikhael, Nofisat Ismaila, M. Cheung, C. Costello +17 more
2019Journal of Clinical Oncology274 citations
Semantic Scholar
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
A. Vijenthira, I. Gong, S. Betschel, M. Cheung +1 more
2021Blood Advances110 citations Open access
Semantic Scholar
Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period
V. Giannakeas, J. Kotsopoulos, M. Cheung, L. Rosella +5 more
2022JAMA Network Open91 citations Open access
Semantic Scholar
Critical illness in patients with hematologic malignancy: a population-based cohort study
B. Ferreyro, D. Scales, H. Wunsch, M. Cheung +4 more
2021Intensive Care Medicine90 citations
Semantic Scholar
CAR T-cells: costs, comparisons, and commentary
A. Hay, M. Cheung
2019Journal of Medical Economics60 citations Open access
Semantic Scholar
Platelet Count and Survival after Cancer
V. Giannakeas, J. Kotsopoulos, Jennifer D. Brooks, M. Cheung +5 more
2022Cancers53 citations Open access
Semantic Scholar
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
I. Gong, A. Vijenthira, M. Powis, A. Calzavara +7 more
2022JAMA Oncology49 citations Open access
Semantic Scholar
Association between diabetes and haematological malignancies: a population-based study
I. Gong, M. Cheung, S. Read, Ying-Bo Na +2 more
2021Diabetologia37 citations Open access
Semantic Scholar
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
Arjun Gupta, A. Hay, M. Crump, M. Djurfeldt +5 more
2023The Oncologist35 citations Open access
Semantic Scholar
Laboratory Workup of Lymphoma in Adults.
S. Kroft, C. Sever, A. Bagg, Brooke L. Billman +11 more
2020Archives of Pathology & Laboratory Medicine32 citations Open access
Semantic Scholar
Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual Care
Gotlib Conn Lesley, H. Tahmasebi, Nicholas Meti, F. Wright +3 more
2021Journal of Patient Experience29 citations Open access
Semantic Scholar
Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects
L. Smyth, D. Blunt, E. Gatov, C. Nagamuthu +3 more
2020British Journal of Haematology27 citations
Semantic Scholar
COVID‐19 vaccine response in patients with hematologic malignancy: A systematic review and meta‐analysis
I. Gong, A. Vijenthira, S. Betschel, L. Hicks +1 more
2022American journal of hematology/oncology26 citations Open access
Semantic Scholar
Predictors of intensive care unit admission in patients with hematologic malignancy
A. Vijenthira, Nicholas Chiu, D. Jacobson, Zoey Freedman +4 more
2020Scientific Reports26 citations Open access
Semantic Scholar
Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival Time.
A. Rahmadian, Seanthel Delos Santos, S. Parshad, Louis Everest +2 more
2020The Journal of the National Comprehensive Cancer Network23 citations Open access
Semantic Scholar
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
A. Vijenthira, K. Chan, M. Cheung, A. Prica
2020The Lancet Haematology23 citations
Semantic Scholar
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada
S. Habbous, X. Tai, J. Beca, J. Arias +18 more
2022JAMA Network Open22 citations Open access
Semantic Scholar
Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort study.
N. Mittmann, Ning Liu, Stephanie Y. Cheng, Soo Seung +8 more
2020CMAJ Open22 citations Open access
Semantic Scholar
Virtual Cancer Care During and Beyond the COVID-19 Pandemic: We Need to Get It Right.
Nicholas Meti, P. Rossos, M. Cheung, S. Singh
2020JCO Oncology Practice20 citations
Semantic Scholar
A user guide to the American Society of Hematology clinical practice guidelines.
A. Izcovich, A. Cuker, R. Kunkle, I. Neumann +14 more
2020Blood Advances20 citations Open access
Semantic Scholar
Association of Immigration Status and Chinese and South Asian Ethnicity With Incidence of Head and Neck Cancer.
Christopher W. Noel, R. Sutradhar, Qing Li, D. Forner +5 more
2020JAMA Otolaryngology - Head and Neck Surgery20 citations Open access
Semantic Scholar
Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies
M. Cheung, R. Croxford, C. Earle, S. Singh
2020Leukemia and Lymphoma20 citations
Semantic Scholar
Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada
Aniket Bankar, Haoyu Zhao, J. Iqbal, Ruth Coxford +4 more
2020Leukemia and Lymphoma19 citations Open access
Semantic Scholar
Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: A Meta-analysis of Randomized Clinical Trials.
R. Saluja, Louis Everest, Sierra Cheng, M. Cheung +1 more
2019JAMA Oncology19 citations Open access
Semantic Scholar
Fracture risk among patients with cancer compared to individuals without cancer: a population-based study
I. Gong, K. W. Chan, L. Lipscombe, M. Cheung +1 more
2023British Journal of Cancer15 citations Open access
Semantic Scholar
Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study.
A. Vijenthira, L. Mozessohn, C. Nagamuthu, Ning Liu +4 more
2022The Journal of the National Comprehensive Cancer Network13 citations
Semantic Scholar
Laboratory Workup of Lymphoma in Adults.
S. Kroft, C. Sever, A. Bagg, Brooke L. Billman +11 more
2020American Journal of Clinical Pathology13 citations
Semantic Scholar
Prevalence of Inappropriateness of Parenteral Vitamin B12 Administration in Ontario, Canada.
William K. Silverstein, Yulia Lin, Christoffer Dharma, R. Croxford +2 more
2019JAMA Internal Medicine13 citations Open access
Semantic Scholar
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry.
D. Blunt, L. Smyth, C. Nagamuthu, E. Gatov +3 more
2021The Journal of the National Comprehensive Cancer Network11 citations
Semantic Scholar
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Louis Everest, Scott Blommaert, D. Tu, J. Pater +3 more
2022Value in Health10 citations
Semantic Scholar
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials.
Mathew Hall, V. A. Krishnanandan, M. Cheung, N. Coburn +3 more
2022Journal of the National Cancer Institute10 citations Open access
Semantic Scholar
Examining the association between oncology drug clinical benefit and the time to public reimbursement
Sasha Thomson, Louis Everest, Noah Witzke, Tina Jiao +4 more
2021Cancer Medicine10 citations Open access
Semantic Scholar
Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process
M. Cheung, B. Franco, Nicholas Meti, A. Thawer +8 more
2021Current Oncology10 citations Open access
Semantic Scholar
Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs
R. Saluja, Tina Jiao, Liza Koshy, M. Cheung +1 more
2021Current Oncology9 citations Open access
Semantic Scholar
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
H. Tilly, F. Morschhauser, L. Sehn, J. Friedberg +28 more
2021Blood9 citations Open access
Semantic Scholar
Preoperative anemia in major elective surgery
Clarissa P. Skorupski, M. Cheung, Yulia Lin
2023Canadian Medical Association Journal8 citations Open access
Semantic Scholar
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
Louis Everest, Bing-Shu E. Chen, A. Hay, M. Cheung +1 more
2023BMC Medical Research Methodology8 citations Open access
Semantic Scholar
Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee
M. Byrne, R. Mattison, R. Bercovitz, R. Lottenberg +13 more
2023Blood Advances8 citations Open access
Semantic Scholar
Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over time.
Sasha Thomson, Noah Witzke, B. Gyawali, Seanthel Delos Santos +4 more
2021European Journal of Cancer8 citations
Semantic Scholar
Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohort
M. Vyas, Ji-Ming Fang, P. Austin, A. Laupacis +3 more
2021BMJ Open8 citations Open access
Semantic Scholar
Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the ‘real-world’
L. Mozessohn, M. Cheung, N. Mittmann, C. Earle +2 more
2020Leukemia and Lymphoma8 citations
Semantic Scholar
Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study
S. Hershenfeld, J. Matelski, V. Ling, M. Paterson +2 more
2020BMJ Open8 citations Open access
Semantic Scholar
Vitamin B12 deficiency
William K. Silverstein, M. Cheung, Yulia Lin
2022Canadian Medical Association Journal7 citations Open access
Semantic Scholar
Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia.
L. Mozessohn, M. Cheung, N. Mittmann, C. Earle +2 more
2020JCO Oncology Practice7 citations
Semantic Scholar
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
L. Mozessohn, Qing Li, Ning Liu, B. Leber +14 more
2023JCO Oncology Practice6 citations Open access
Semantic Scholar
Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
Aniket Bankar, W. Chan, Ning Liu, M. Cheung +2 more
2023Blood Advances6 citations Open access
Semantic Scholar
The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group
K. Chan, M. Cheung, D. Regier, A. Hay +5 more
2021Current Oncology6 citations Open access
Semantic Scholar
Chinese and South Asian ethnicity, immigration status and head and neck cancer outcomes: A population based study.
Christopher W. Noel, R. Sutradhar, Qing Li, D. Forner +5 more
2020Oral Oncology6 citations
Semantic Scholar
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario
A. Suleman, S. Aktar, Z. Ante, Ning Liu +3 more
2023British Journal of Haematology5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Mozessohn×8
Invite
L. Mozessohn — researcher profile on SciRah
K. Chan×8
Invite
K. Chan — researcher profile on SciRah
C. Earle×7
Invite
C. Earle — researcher profile on SciRah
A. Vijenthira×6
Invite
A. Vijenthira — researcher profile on SciRah

×6

Invite

S. Singh — researcher profile on SciRah

Invite

I. Gong — researcher profile on SciRah

Invite

A. Hay — researcher profile on SciRah

Louis Everest×5

Invite

Louis Everest — researcher profile on SciRah

Invite

N. Mittmann — researcher profile on SciRah

Invite

A. Prica — researcher profile on SciRah

Invite

L. Hicks — researcher profile on SciRah

L. Lipscombe×4

Invite

L. Lipscombe — researcher profile on SciRah